Use of an immunogenic composition comprising of VZV GE, or one of its Fragments immunogens.And a th-1 adjuvant in the preparation of a Medicament for the Prevention or Relief of herpes zoster and / or postherpetic neuralgia.Also, compositions comprising a truncated VZV GE Antigen and an adjuvant containing QS21, cholesterol and 3D MPL.Claim 12: a procedure to prevent and / or reduce the severity of herpes zoster and / or postherpetic neuralgia.Understanding the procedure administered to an individual that needs an effective amount of a composition comprising of VZV GE, or one of its Fragments immunogens, and an adjuvant TH - 1.Claim 13: a vaccine or immunogenic composition consisting essentially of a truncated VZV GE Antigen to remove the anchor region of the carboxyl terminal in combination with a AdyIntervener comprising QS21, and 3D MPL Liposomes containing cholesterol.Claim 18: a kit comprising a VZV Live Attenuated or Inactivated VZV and, separately, a VZV Antigen or one of its derived immunogens.The suitable Components for concomitant or Sequential, or mixing as a unique composition before Administration.Claim: a kit comprising 19 as separate components, a th-1 adjuvant and Antigen GE or its Fragments immunogens.Suitable for the extemporaneous preparation of a vaccine composition for the Prevention or Relief of herpes zoster and / or postherpetic neuralgia.Uso de una composición inmunógena que comprende gE de VZV, o uno de sus fragmentos inmunógenos, y un adyuvante TH-1 en la preparación de un medicamento para la prevención o alivio de herpes zoster y/o neuralgia postherpética. También se reivindican composiciones que comprenden un antígeno gE de VZV truncado y un adyuvante que contiene QS21, colesterol y 3D MPL. Reivindicación 12: Un procedimiento para prevenir y/o reducir la gravedad de herpes zoster y/o neuralgia postherpética, comprendiendo el procedimiento administrar a un individuo que lo necesite una cantidad eficaz de una composición que comprende
